ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025
Low-dose radiotherapy as a definitive treatment for Kimura's disease.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeKimura disease (KD) is characterized by inflammatory granulomas with eosinophilic infiltration in young males. The characteristic large mass in the head and neck region poses esthetic concerns. Treatment may include corticosteroid administration, surgery, or both; however, these often result in recurrence. Low-dose radiation therapy (RT) is a second-line treatment option for KD and is mainly used for recurrence or as adjuvant therapy after surgery. In this study, we aimed to evaluate the outcomes of RT alone as a definitive treatment for seven patients with KD refractory to oral corticosteroids.
methodsThis study included male patients with a median age of 37 years and median disease duration of 9 years. The lesion sites included the unilateral or bilateral cheek and auricular areas. RT was administered at a dose of 1.8 Gy per fraction five times per week for a total of 30.6 Gy. Their adverse events and predictive biomarkers were evaluated.
resultsThe maximal diameter of the mass significantly reduced from 10 ± 3.8 cm (mean ± SD) to 4.1 ± 1.9 cm without regrowth for 99 months. Peripheral blood eosinophil counts significantly decreased from 2,435 ± 241 to 1,106 ± 411/µL at one year after RT. The acute adverse events included grade 1 dermatitis and dry mouth in five patients, pharyngitis in 3, and alopecia in 2, all of which improved a few months after RT.
conclusionRT is a satisfactory treatment for patients with corticosteroid-resistant KD with acceptable adverse events. The peripheral blood eosinophil count may be a useful biomarker for determining the disease status of KD.
Indexed as
Identifiers
40500513What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.